REVEALING UNDERSTANDINGS: THIS POTENTIAL OF BLOCKING TYPE II INTERFERON IMMUNOGLOBULIN R4-6A2

Researchers are increasingly leveraging the specific capabilities of the R4-6A2 reagent – an effective tool for blocking mouse IFNγ. This methodology allows for a more thorough examination of immune cell function, particularly in models of inflammation and autoimmunity, where IFNγ frequently play